196 related articles for article (PubMed ID: 18187580)
1. Functional evolution of the p53 regulatory network through its target response elements.
Jegga AG; Inga A; Menendez D; Aronow BJ; Resnick MA
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):944-9. PubMed ID: 18187580
[TBL] [Abstract][Full Text] [Related]
2. Evolution of p53 transactivation specificity through the lens of a yeast-based functional assay.
Lion M; Raimondi I; Donati S; Jousson O; Ciribilli Y; Inga A
PLoS One; 2015; 10(2):e0116177. PubMed ID: 25668429
[TBL] [Abstract][Full Text] [Related]
3. Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation.
Tomso DJ; Inga A; Menendez D; Pittman GS; Campbell MR; Storici F; Bell DA; Resnick MA
Proc Natl Acad Sci U S A; 2005 May; 102(18):6431-6. PubMed ID: 15843459
[TBL] [Abstract][Full Text] [Related]
4. Divergent evolution of human p53 binding sites: cell cycle versus apoptosis.
Horvath MM; Wang X; Resnick MA; Bell DA
PLoS Genet; 2007 Jul; 3(7):e127. PubMed ID: 17677004
[TBL] [Abstract][Full Text] [Related]
5. Whole-genome cartography of p53 response elements ranked on transactivation potential.
Tebaldi T; Zaccara S; Alessandrini F; Bisio A; Ciribilli Y; Inga A
BMC Genomics; 2015 Jun; 16(1):464. PubMed ID: 26081755
[TBL] [Abstract][Full Text] [Related]
6. Noncanonical DNA motifs as transactivation targets by wild type and mutant p53.
Jordan JJ; Menendez D; Inga A; Noureddine M; Bell DA; Resnick MA
PLoS Genet; 2008 Jun; 4(6):e1000104. PubMed ID: 18714371
[TBL] [Abstract][Full Text] [Related]
7. Potentiating the p53 network.
Menendez D; Inga A; Resnick MA
Discov Med; 2010 Jul; 10(50):94-100. PubMed ID: 20670604
[TBL] [Abstract][Full Text] [Related]
8. Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence.
Inga A; Storici F; Darden TA; Resnick MA
Mol Cell Biol; 2002 Dec; 22(24):8612-25. PubMed ID: 12446780
[TBL] [Abstract][Full Text] [Related]
9. Interactions of chromatin context, binding site sequence content, and sequence evolution in stress-induced p53 occupancy and transactivation.
Su D; Wang X; Campbell MR; Song L; Safi A; Crawford GE; Bell DA
PLoS Genet; 2015 Jan; 11(1):e1004885. PubMed ID: 25569532
[TBL] [Abstract][Full Text] [Related]
10. Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity.
Resnick MA; Inga A
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9934-9. PubMed ID: 12909720
[TBL] [Abstract][Full Text] [Related]
11. Functional diversity in the gene network controlled by the master regulator p53 in humans.
Resnick MA; Tomso D; Inga A; Menendez D; Bell D
Cell Cycle; 2005 Aug; 4(8):1026-9. PubMed ID: 16082206
[TBL] [Abstract][Full Text] [Related]
12. Changing the p53 master regulatory network: ELEMENTary, my dear Mr Watson.
Menendez D; Inga A; Jordan JJ; Resnick MA
Oncogene; 2007 Apr; 26(15):2191-201. PubMed ID: 17401428
[TBL] [Abstract][Full Text] [Related]
13. Differential recognition of response elements determines target gene specificity for p53 and p63.
Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
[TBL] [Abstract][Full Text] [Related]
14. PhyloGibbs: a Gibbs sampling motif finder that incorporates phylogeny.
Siddharthan R; Siggia ED; van Nimwegen E
PLoS Comput Biol; 2005 Dec; 1(7):e67. PubMed ID: 16477324
[TBL] [Abstract][Full Text] [Related]
15. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
16. Identification of p53-target genes in Danio rerio.
Mandriani B; Castellana S; Rinaldi C; Manzoni M; Venuto S; Rodriguez-Aznar E; Galceran J; Nieto MA; Borsani G; Monti E; Mazza T; Merla G; Micale L
Sci Rep; 2016 Sep; 6():32474. PubMed ID: 27581768
[TBL] [Abstract][Full Text] [Related]
17. The UV responsive elements in the human mimecan promoter: a functional characterization.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jan; 9():1-9. PubMed ID: 12533723
[TBL] [Abstract][Full Text] [Related]
18. Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation.
Jordan JJ; Inga A; Conway K; Edmiston S; Carey LA; Wu L; Resnick MA
Mol Cancer Res; 2010 May; 8(5):701-16. PubMed ID: 20407015
[TBL] [Abstract][Full Text] [Related]
19. Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts.
Noureddine MA; Menendez D; Campbell MR; Bandele OJ; Horvath MM; Wang X; Pittman GS; Chorley BN; Resnick MA; Bell DA
PLoS Genet; 2009 May; 5(5):e1000462. PubMed ID: 19424414
[TBL] [Abstract][Full Text] [Related]
20. P53 family members modulate the expression of PRODH, but not PRODH2, via intronic p53 response elements.
Raimondi I; Ciribilli Y; Monti P; Bisio A; Pollegioni L; Fronza G; Inga A; Campomenosi P
PLoS One; 2013; 8(7):e69152. PubMed ID: 23861960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
